The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling...

Area of Science:

• Molecular Biology
• Oncology
• Cell Signaling

Background:

• The DNA damage response (DDR) and mitogen-activated protein kinase (MAPK) pathways are essential for cellular survival and organismal homeostasis.
• Crosstalk between DDR and MAPK signaling is critical for multicellular organism function.
• Dysregulation of these pathways contributes to cancer development, progression, and drug resistance.

Purpose of the Study:

• To review current knowledge on alterations in DDR and MAPK signaling in multiple myeloma.
• To explore the functional crosstalk between DDR and MAPK in this hematologic malignancy.
• To highlight recent advances in anti-myeloma drug development targeting these pathways.

Main Methods:

• Literature review of studies on DDR, MAPK signaling, and multiple myeloma.
• Analysis of existing data on molecular alterations and therapeutic targets.
• Synthesis of information on drug development and clinical trial design.

Main Results:

• Aberrations in DDR and MAPK pathways are prevalent in multiple myeloma.
• Abnormal DDR/MAPK crosstalk contributes to multiple myeloma pathogenesis.
• Novel drugs targeting DDR and MAPK components are emerging for anti-myeloma therapy.

Conclusions:

• Understanding DDR and MAPK alterations in multiple myeloma is crucial for therapeutic innovation.
• Targeting DDR and MAPK pathways holds promise for new treatment strategies.
• Combination therapies involving DDR and MAPK inhibitors may enhance anti-myeloma efficacy.